0001695295-26-000010
SEC filingHydrofarm Holdings Group, Inc. reported a significant net loss of $289.8 million for fiscal year 2025, driven by a $232.2 million impairment charge on long-lived assets and continued operating losses. Net sales declined to $134.3 million from $190.3 million in the prior year, reflecting adverse market conditions including an agricultural oversupply impacting the cannabis industry and reduced indoor cultivation. The company's gross profit was $15.2 million, resulting in a gross margin of 11.3%. Operating cash flow was negative $14.1 million, and the company faces substantial doubt about its ability to continue as a going concern due to recurring losses, negative cash flows, and significant debt obligations due within twelve months. Management is implementing restructuring plans and pursuing strategic alternatives to improve liquidity.
Hydrofarm Holdings Group, Inc. reported severely deteriorated financial results for fiscal year 2025. The company recorded a net loss of $289.8 million, significantly worse than the $66.7 million loss in the prior year. This was primarily driven by a $232.2 million impairment charge on long-lived assets, reflecting adverse industry conditions. Net sales declined 29.5% to $134.3 million from $190.3 million in 2024. The company's loss from operations was $276.9 million compared to $52.2 million in the prior year. Basic and diluted loss per share was $62.00, compared to $14.51 in 2024. The company's financial statements include a going concern qualification from its auditor due to recurring operating losses, negative cash flows, and significant debt obligations due within twelve months.
The company's revenue decline to $134.3 million reflects challenging market conditions in the controlled environment agriculture industry. Management attributes the decline primarily to an agricultural oversupply impacting the cannabis market, resulting in decreased indoor and outdoor cultivation. Additionally, demand was negatively impacted by the extended period to enact reform of U.S. federal cannabis regulations, including rescheduling, which led cannabis operators to reduce investments in products, particularly durable goods. The company also noted negative impacts from hydroponic retail store closings and associated accounts receivable allowances. Geographically, U.S. operations generated $107.8 million in sales while Canadian operations contributed $29.1 million, with both regions experiencing significant declines from the prior year.
Gross profit declined to $15.2 million from $32.1 million in the prior year, with gross margin contracting to 11.3% from 16.9%. This margin pressure reflects the challenging sales environment and product mix changes. Selling, general and administrative expenses were $59.9 million, down from $72.8 million in the prior year, reflecting cost reduction efforts. However, the $232.2 million impairment charge on finite-lived intangible assets and property, plant and equipment drove the substantial operating loss. The impairment was triggered by industry conditions, primarily attributable to agricultural oversupply impacting the market and resulting in decreased cultivation, as well as continued declines in operating cash flows and profitability.
Operating activities used $14.1 million in cash during 2025, compared to $0.3 million used in the prior year. Investing activities used $0.8 million, primarily for capital expenditures. Financing activities used $5.4 million, including $4.9 million in Term Loan repayments. The company ended the year with $6.3 million in cash and cash equivalents, down from $26.1 million at the end of 2024. The balance sheet shows total current liabilities of $140.0 million exceeding total current assets of $51.4 million, with $111.9 million of current portion of long-term debt. Total liabilities were $187.1 million against total assets of $123.8 million, resulting in a stockholders' deficit of $63.3 million. The company has significant debt obligations, including a Term Loan with $114.4 million principal outstanding.
Management has disclosed substantial doubt about the company's ability to continue as a going concern. The company is implementing restructuring plans to reduce costs, including the 2025 Restructuring Plan expected to result in annual cost savings of over $6 million. Management is negotiating with lenders and key vendors and pursuing additional financing or strategic alternatives, including the sale of assets or businesses, or an offering of equity securities. The company faces significant risks including its ability to meet working capital needs and contractual obligations, possible difficulties in raising sufficient capital, competitive industry pressures, and federal and state regulations pertaining to the cannabis industry. Market conditions remain challenging with continued agricultural oversupply impacting demand.